en · de · es · fr · pt
aod-9604-notes.peptides4800.com › Faq › Background And Molecular Identity — Background and Details

Background And Molecular Identity — Background and Details

By Editorial Desk · published 2026-03-08 · last reviewed 2026-04-08 · Faq

Everything below concerns peptide mapping. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Last reviewed on 2026-04-08. Where a claim depends on a specific study, the study is described rather than over-claimed.

Background and Molecular Identity

The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.

Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.

AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.

Identity and Research Context

Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.

AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.

Aod-9604 at a glance

PropertyValueNotes
Molecular classSynthetic peptideBased on the C-terminal region of human growth hormone.
Amino acid length16 residuesOften described as hGH fragment 176-191.
AppearanceLyophilized powderTypically white to off-white; exact appearance depends on grade.
SolubilitySoluble in waterAqueous solubility depends on pH, ionic strength, and preparation.
Typical storage-20 °C or lowerLyophilized peptide is usually kept cold and dry; solutions may require freezing.

Handling And Analytical Properties

Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.

Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.

Related pages on this site

Background And Research Context

In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.

AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.

Handling, Analysis, and Quality Control

Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.

Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.

Regulatory and Analytical Context

In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.

Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.

Notes from published material

Shaka was the illegitimate son of Senzangakhona, Chief of the Zulus. He was born c. 1787. He and his mother, Nandi, were exiled by Senzangakhona, and found refuge with the Mthethwa. Shaka fought as a warrior under Dingiswayo, leader of the Mthethwa Paramountcy. When Senzangakona died, Dingiswayo helped Shaka become king of the Zulu. After Dingiswayo's death at the hands of Zwide, king of the Ndwandwe, around 1816, Shaka assumed leadership of the entire Mthethwa alliance. Shaka expanded the Zulu Kingdom through war and diplomacy. Shaka's clan at first numbered no more than a few thousands, but eventually grew in size to 45,000 after absorbing neighbouring clans. His military reforms included new battle techniques, training, and tough discipline, as well as the replacement of long throwing spears in exchange for the more effective short stabbing spears. Conscripted men were segregated from the rest of Zulu society to be trained as an organised standing army called the amabutho. The alliance under his leadership survived Zwide's first assault at the Battle of Gqokli Hill (1818). Within two years, Shaka had defeated Zwide at the Battle of Mhlatuze River (1820) and broken up the Ndwandwe alliance. The Ngoni people fled as far north as Tanzania and Malawi. By 1822, Shaka had conquered an empire covering an area of around 80,000 square miles (210,000 km2), covering Pongola to the Tugera Rivers.

The two substrates of this enzyme are L-xylose and oxidised nicotinamide adenine dinucleotide phosphate (NADP+). Its products are L-xylono-1,4-lactone, reduced NADPH, and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is L-xylose:NADP+ 1-oxidoreductase. Other names in common use include L-xylose dehydrogenase, and NADPH-xylose reductase.

=== History === Decoction of the leaves, bark or roots was used as a traditional remedy. During World War II, most fruits rich in vitamin C, such as oranges, became difficult to obtain in the United Kingdom, as they were mainly imported. Since blackcurrant berries are a rich source of the vitamin, and blackcurrant plants are suitable for growing in the UK climate, the British Government encouraged their cultivation and soon the yield of the nation's crop increased significantly. From 1942 onwards, blackcurrant syrup was distributed free of charge to children under the age of two. This may have given rise to the lasting popularity of blackcurrant as a flavouring in Britain. In Britain the commercial crop is completely mechanised and about 1,400 hectares of the fruit are grown, mostly under contract to the juicing industry. Commercially, most large-scale cultivation of blackcurrants is done in eastern Europe for the juice and juice concentrate market. As of 2017, major cultivation efforts to improve fruit characteristics occurred in Scotland, New Zealand, and Poland. Blackcurrants were once popular in the United States as well, but became less common in the 20th century after currant farming was banned in the early 1900s, when blackcurrants, as a vector of white pine blister rust, were considered a threat to the U.S. logging industry. The federal ban on growing currants was shifted to the jurisdictions of individual states in 1966, and was lifted in New York State in 2003 through the efforts of horticulturist Greg Quinn.

== Physiology == Cholesterol is essential for all animal life. While most cells are capable of synthesizing it, the majority of cholesterol is ingested or synthesized by hepatocytes and transported in the blood to peripheral cells. The levels of cholesterol in peripheral tissues are dictated by a balance of uptake and export. Under normal conditions, brain cholesterol is separate from peripheral cholesterol, i.e., the dietary and hepatic cholesterol do not cross the blood brain barrier. Rather, astrocytes produce and distribute cholesterol in the brain. De novo synthesis, both in astrocytes and hepatocytes, occurs by a complex 37-step process. This begins with the mevalonate or HMG-CoA reductase pathway, the target of statin drugs, which encompasses the first 18 steps. This is followed by 19 additional steps to convert the resulting lanosterol into cholesterol. A human male weighing 68 kg (150 lb) normally synthesizes about 1 gram (1,000 mg) of cholesterol per day, and his body contains about 35 g, mostly contained within the cell membranes. Typical daily cholesterol dietary intake for a man in the United States is 307 mg. Most ingested cholesterol is esterified, which causes it to be poorly absorbed by the gut. The body also compensates for absorption of ingested cholesterol by reducing its own cholesterol synthesis. For these reasons, cholesterol in food, seven to ten hours after ingestion, has little, if any effect on concentrations of cholesterol in the blood.

He declined to travel to El Salvador to see Abrego Garcia, but said that his office was "looking at all available options to ensure that due process is going to be followed by El Salvador". In February 2026, after it was reported that the U.S. Department of Homeland Security had purchased a warehouse in Washington County with plans to renovate it into an immigration detention facility, Moore ordered state agency heads and the attorney general of Maryland to review the federal government's purchase of the facility. He also wrote to Homeland Security Secretary Kristi Noem expressing concerns about the economic impacts the facility would have on the local area as well as the "troubling lack of transparency" around the purchase. That same month, he signed into law a bill to prohibit counties from entering into 287(g) program agreements with U.S. Immigration and Customs Enforcement (ICE). In May 2026, Moore signed into law a bill that prohibits law enforcement officers from wearing face coverings with exceptions for officers involved in undercover operations. In April 2026, Moore signed into law the Maryland Values Act of 2026, which prohibits public school employees from assisting with immigration enforcement and requires public school employees to alert their local superintendents of immigration enforcement activities at schools.

Sources: en.wikipedia.org

Background from the literature

== Fetomaternal microchimerism in the brain == Several studies have identified male DNA in the brains of female humans and mice who have previously been pregnant with a male fetus. It has been suggested that the fetal-derived cells can differentiate into those capable of presenting immunomarkers on their surface. There has been no strong evidence to say microchimerism of the maternal brain leads to disease; however, Parkinson's disease correlates with a higher incidence of brain microchimeras. Alzheimer's disease studies support nearly the opposite correlation: the more fetal-derived cells present, the lower the chance of the patient having had Alzheimer's.

=== Industrial === Chitin is used in many industrial processes. Examples of the potential uses of chemically modified chitin in food processing include the formation of edible films and as an additive to thicken and stabilize foods and food emulsions. Processes to size and strengthen paper employ chitin and chitosan.

Members of the Arcobacter genus are the primary early colonizers (<24 months). Sulfurospirillum genus members colonize at ~50 months, during the transitional stages of organic carbon breakdown. The Sulfurimonas genus dominates at >140 months, and are key players in its symbiosis with the Osedax host. The Sulfurimonas genus in particular protects the Osedax worms from potentially harmful by-products produced at >140 months of the whale fall degradation. The Sulfurimonas bacteria house the type II and IV sulfide:quinone oxidoreductase genes that encode enzymes to oxidize and assimilate sulfide. These reactions prevent the host from absorbing toxic by-products across the epithelial barrier.

== Dietary recommendations == Some research shows that most people in the United States and the United Kingdom consume sufficient vitamin B12. However, other research suggests that the proportion of people with low or marginal levels of vitamin B12 is up to 40% in the Western world. Grain-based foods can be fortified by having the vitamin added to them. Vitamin B12 supplements are available as single or multivitamin tablets. Pharmaceutical preparations of vitamin B12 may be given by intramuscular injection. Since there are few non-animal sources of the vitamin, vegans are advised to consume a dietary supplement or fortified foods for B12 intake, or risk serious health consequences. Children in some regions of developing countries are at particular risk due to increased requirements during growth coupled with diets low in animal-sourced foods. The US National Academy of Medicine updated estimated average requirements (EARs) and recommended dietary allowances (RDAs) for vitamin B12 in 1998. The EAR for vitamin B12 for women and men ages 14 and up is 2.0 μg/day; the RDA is 2.4 μg/d. RDA is higher than EAR to identify amounts that will cover people with higher-than-average requirements. RDA for pregnancy equals 2.6 μg/day. RDA for lactation equals 2.8 μg/d. For infants up to 12 months, the adequate intake (AI) is 0.4–0.5 μg/day. (AIs are established when there is insufficient information to determine EARs and RDAs.) For children ages 1–13 years, the RDA increases with age from 0.9 to 1.8 μg/day.

Sources: en.wikipedia.org

Reference notes

As a prototypical transaminase, AST relies on PLP (vitamin B6) as a cofactor to transfer the amino group from aspartate or glutamate to the corresponding ketoacid. In the process, the cofactor shuttles between PLP and the pyridoxamine phosphate (PMP) form. The amino group transfer catalyzed by this enzyme is crucial in both amino acid degradation and biosynthesis. In amino acid degradation, following the conversion of α-ketoglutarate to glutamate, glutamate subsequently undergoes oxidative deamination to form ammonium ions, which are excreted as urea. In the reverse reaction, aspartate may be synthesized from oxaloacetate, which is a key intermediate in the citric acid cycle.

Archimedes reportedly exclaimed "Eureka" after he realized how to detect whether a crown is made of impure gold. While he did not use Archimedes' principle in the widespread tale and used displaced water only for measuring the volume of the crown, there is an alternative approach using the principle: Balance the crown and pure gold on a scale in the air and then put the scale into water. According to Archimedes' principle, if the density of the crown differs from the density of pure gold, the scale will get out of balance under water.

In the case of molecular studies, the preservation of a specimen that can vouch for the source of the tissue sample used to gather genetic data has been recommended, as genetic analysis often yields surprising results that make reexamination of the original specimen crucial. Studies on ectoparasites, usually obtained during capture, but also obtained from old museum specimens, are valuable for studies on coevolution and zoonoses. In addition to taxonomic research, collections can provide information relevant to the study of variety of other ornithological questions, including comparative anatomy, ecology, behavior, disease, and conservation. Forensic ornithologists use collections to identify species involved in aircraft bird strikes, imported materials containing bird parts, and birds killed through various human activities, legal and illegal. In addition, collections are used by zooarchaeologists to identify bird bones at prehistoric human sites or species of origin for feathers used in human cultural artifacts. Collections also have been heavily used by artists, particularly for the production of plates for ornithological field guides. The close-up observation and opportunity for manipulation provided by preserved study skins makes them, together with field observations and photography, to be an important basis for painters of field guide plates of birds. Most bird species have several unique plumages that distinguish immature from adults, males from females, and breeders from non-breeders.

=== Multishot needle syringes === There are needle syringes designed to reload from a built-in tank (container) after each injection, so they can make several or many injections on a filling. These are not used much in human medicine because of the risk of cross-infection via the needle. An exception is the personal insulin autoinjector used by diabetic patients and in dual-chambered syringe designs intended to deliver a prefilled saline flush solution after the medication.

== Early life == Melksham grew up in Glenroy, Victoria; as a junior, he played for the Oak Park Football Club in the Essendon District Football League, and attended Penleigh and Essendon Grammar School. Joining the Calder Cannons under 18 side in the TAC Cup as a bottom-aged player in 2007 at sixteen years of age, a bout of osteitis pubis set in towards the end of the year, which hampered his summer training and saw him miss several games during the 2008 season. In 2008, he was awarded a scholarship with the Australian Institute of Sport (AIS) as part of AIS-AFL Academy in their eleventh intake. Melksham spent his final year as a junior playing for the Calder Cannons, which saw the club win their fifth premiership when they defeated the Dandenong Stringrays by fourteen points in the grand final. His performance in the grand final saw him adjudged the best on ground and he was awarded the TAC Medal after he recorded twenty-four disposals and seven inside-50s. He received mid-year state honours when he represented Vic Metro in the 2009 AFL Under 18 Championships and prior to the start of the competition he was labelled by The Age journalist, Emma Quayle, as one of the "players to watch" during the championships. He averaged eighteen disposals during the championships and ranked second overall for Vic Metro in clearances and score assists, behind eventual number one draft pick, Tom Scully. After a slow start to the year, he had a strong finish to the year, which elevated his draft chances to inside the top ten.

Sources: en.wikipedia.org

Frequently asked questions

What is AOD-9604?

It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.

Is AOD-9604 the same as human growth hormone?

No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.

Does AOD-9604 occur naturally?

The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.

What is AOD-9604?

AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.

Network